The world’s most famous blue man, Paul Karason, also dubbed Papa Smurf, was born as a fair-skinned, freckled boy with ginger hair. In the 2000s, he became an internet sensation and made many TV appearances, openly talking about his condition. Let’s find out together why Karason turned blue and how he became a cautionary tale.
Paul Karason had a skin condition that made his skin flake, as well as acid reflux and arthritis. Doing his own research in order to improve these ailments, he found out about a solution of silver in water, also known as colloidal silver.
Colloidal silver was widely used as an antibiotic back before penicillin was invented in the 1930s. It was banned in 1999 in over-the-counter medications after scientists found that it can severely damage internal organs.
The late Paul Karason and his wife, Joanne
Karason drank what he believed was a miracle cure for over 10 years. Moreover, he even began to apply a silver preparation directly to his skin; he claimed his acid reflux and arthritis just went away. “I had arthritis in my shoulders so bad I couldn’t pull a T-shirt off. And the next thing I knew, it was just gone,” he shared.
Due to the silver accumulation in his skin, he started to turn blue and suffered from a permanent and rare condition called argyria. Only when Karason met an old friend who asked him, “What have you done to yourself?” did he begin to realize he’d become blue.
Karason claimed his blue skin had many advantages — he never got sunburns or had to wear sunglasses. There were some side effects he did not appreciate, however, such as folks “being less than polite” to him. Moreover, Karason confessed he couldn’t get a job because of employers’ resistance to hiring “people that are blue or that are noticeably different.”
Sadly, Paul Karason passed away in 2013 when he was 62 years old due to heart complications.
Papa Smurf’s story serves as a valuable lesson about the importance of being careful when it comes to at-home remedies. While it’s natural to want to find easy solutions to health problems, it’s important to be aware that such remedies can sometimes pose serious risks. It’s always better to consult a doctor and follow their advice for a safe and effective treatment.
Meet Twins with the Rare Benjamin Button Syndrome, Who Became Symbols of Resilience
In a small Brazilian town, there resides an extraordinary duo of identical twins named Elis and Eloá. Their story serves as a beacon of resilience and the remarkable power of the human spirit. Afflicted with Hutchinson-Gilford Progeria Syndrome, a rare and fatal genetic disorder causing accelerated aging, these twins confront their adversities with remarkable grace and strength, earning admiration from people worldwide.
Understanding Hutchinson-Gilford Progeria syndrome
HGPS stands as an exceptionally rare disorder, impacting roughly 1 in 20 million newborns globally. Marked by rapid aging from early childhood, individuals with progeria often display growth delays, diminished body fat and hair, prematurely aged skin, joint stiffness, and severe cardiovascular issues. Typically, those with HGPS have an average life expectancy of about 14.5 years, though some may extend into their late teens or early twenties. This syndrome gained public attention through the film The Curious Case of Benjamin Button.
The condition is caused by a mutation in the LMNA gene, which produces the lamin A protein responsible for maintaining the structural integrity of the cell nucleus. The mutation results in the production of an abnormal version of the protein, called progerin, which causes cells to become unstable and die prematurely.
Elis and Eloá’s journey
Elis and Eloá swiftly captured attention because of their distinctive medical condition. Despite the physical hurdles imposed by progeria, their contagious smiles and steadfast optimism have emerged as beacons of hope and inspiration. Guilherme and Elismar, the twins’ parents, have dedicated their lives to offering the utmost care for their daughters, striving to ensure they experience as normal a life as feasible within the confines of their condition.
The family’s path has been far from easy. Their daily life is filled with demanding medical routines, including physiotherapy, aimed at addressing joint stiffness and preserving mobility. Despite these challenges, Elis and Eloá approach each day with remarkable bravery and an unparalleled enthusiasm for life, which is truly remarkable.
A global community of support
Elis and Eloá’s narrative has touched hearts worldwide, sparking a surge of solidarity from individuals and groups committed to promoting awareness about progeria and backing research endeavors. The Progeria Research Foundation, a pivotal entity in this realm, has played a vital role in propelling research forward and furnishing assistance to families grappling with the condition.
Through social media platforms, the twins’ journey is shared with a broad audience, fostering a sense of community and solidarity. Their family’s updates, documenting both the highs and lows of their daily lives, provide invaluable insights into the realities of living with progeria, while also spreading a message of hope and perseverance.
Advances in research and hope for the future
In recent years, there have been remarkable advancements in comprehending and addressing progeria. A notable milestone occurred in 2020 when the U.S. Food and Drug Administration (FDA) granted approval for the first progeria treatment: lonafarnib. This medication has demonstrated efficacy in prolonging the lives of children with progeria by mitigating the accumulation of progerin in cells, thereby decelerating the disease’s advancement.
Though a cure remains elusive, ongoing research presents promising prospects. Scientists are delving into gene-editing methodologies, like CRISPR, as potential means to rectify the genetic mutation at its root. For families such as Elis and Eloá’s, these breakthroughs offer a ray of hope for the future.
And in our other article, we recounted the remarkable story of a girl born without a nose, affectionately dubbed “Voldemort,” who refuses to let her differences define her.
Leave a Reply